Companies /Healthcare

Boston Scientific Corp

NYSE: BSX Medical Devices
$44.17
▼ $0.03 (−0.07%) today
Markets open · 12:39pm ET

24/7 Wall St. View

Price Prediction $51.66 +16.9% Our analysts’ 12-month view: target, optimistic case, and floor. BSX price prediction → Earnings Beat +0.9% EPS vs. the estimate, revenue, and how the market reacted. BSX earnings history →

BSX at a Glance

Valuation
Market cap
$64.1B
P/E ratio
18.7
Profitability
Revenue (TTM)
$21.1B
Profit margin
16.6%
EPS (TTM)
$2.37
Price
52-week range
$40 – $103
24/7 target
$51.66
Street target
$49.60
Earnings
Next report
Feb 2, 2027
Q3 2026 EPS
$0.73
vs. $0.72 est.
+0.9%

Headquartered in Marlborough, MA Fiscal year ends December NYSE: BSX bostonscientific.com

About Boston Scientific

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a broad range of interventional and implantable medical devices. The company operates through two reportable segments: MedSurg (encompassing Endoscopy, Urology, and Neuromodulation) and Cardiovascular. Its product portfolio spans devices and therapies that help physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions. Key product platforms include the WATCHMAN left atrial appendage closure device, LithoVue ureteroscopy systems, the StoneSmart kidney stone solutions ecosystem, SEISMIQ intravascular lithotripsy catheters, the AVVIGO multi-modality guidance system, and the eCoin implantable tibial nerve stimulation system. The company serves healthcare providers globally across the United States, EMEA, Asia-Pacific, and Latin America markets. Boston Scientific has been in operation for more than 45 years and trades on the NYSE under the ticker BSX. Updated

Revenue by Segment · Q3 2026
  1. Cardiovascular66%
  2. MedSurg34%

Latest Activity

BSXBoston Scientific
After-hours
$44.12
+4.59%open $42.18

A 4.59% run to $44.12 adds close to $3 billion of market value to a $63.9 billion medtech name that rarely moves this much in a single session. Whether the gain holds through the next open is the tell.

Read more
Biggest movers · At the close
Gainers
  • VRTVertiv$243.72+16.9%
  • SKHYSK hynix$164.45+13.1%
  • ORCLOracle$145.27+11.3%
  • FNFabrinet$368.47+7.4%
  • SNDKSanDisk$1,400.83+7.4%
Losers
  • BKRBaker Hughes$54.78-7.2%
  • BSXBoston Scientific$42.25-6.3%
  • SANBanco Santander$11.71-6.1%
  • FTNTFortinet$174.37-5.8%
  • GRMNGarmin$272.79-5.7%

Vertiv closed up 16.86% at $243.72, the widest single-name gain across our 382-stock priority list today.

Read more
BSXBoston Scientific
Regular session
$40.27
-4.03%open $41.96

A 4% slide to $40.27 on the day Q3 results landed puts the $58 billion device maker's guidance under the microscope. Moves this size are rare for a name that usually trades like a steady compounder.

Read more
Biggest movers · On the open
Gainers
  • VRTVertiv$232.61+11.5%
  • SKHYSK hynix$160.16+10.2%
  • SNDKSanDisk$1,380.36+5.8%
  • MUMicron Technology$976.34+5.1%
  • APHAmphenol$82.08+5.0%
Losers
  • BSXBoston Scientific$40.6-9.9%
  • TERTeradyne$298.64-7.7%
  • TELTE Connectivity$211.87-6.0%
  • GSKGSK$48.05-5.7%
  • STXSeagate Technology$633.24-5.2%

Vertiv's 11.5% jump tops the open, and the spread to Boston Scientific at the bottom runs better than 21 points. Hardware names fill both lists, so owning the sector is no guarantee of being on the right side today.

Read more
BSXBoston Scientific
Q3 2026
EPS
$0.73
est $0.72+0.9%
Revenue
$5.14B
est $5.05B+1.7%

Management guided Q4 sales to decline 1% to 3% as fallout from the August cybersecurity incident keeps hitting operations. The six-quarter beat streak now runs into a shrinking top line.

Quarterly EPS — reported vs estimate
Read more
BSXBoston Scientific Corporation
Reports Wed Oct 28Before openConfirmed

Fourteen straight quarters of EPS beats go on the line at 6:30 AM ET, with consensus at $0.72 on $5.05 billion in revenue. Anything short of that breaks a streak the market has been paying up for.

    Read more
    BSXBoston Scientific
    New 52-week low$42.6-0.1% vs prior low · 2026-07-14

    Boston Scientific just set a fresh 52-week low at $42.60, undercutting its mid-July floor. No bounce has held since the stock broke down from triple digits a year ago.

    Read more
    House trade disclosureKevin Hern
    • AAPLApple Inc. - Common Stock (AAPL)Partial sell$1K – $15KSep 8
    • AAPLApple Inc. - Common Stock (AAPL)Partial sell$1K – $15KSep 8
    • ARBUCKLE MEM HOSP AUTH OKLA SALES TAX 03.00000% 01/01/2027 REV BDS SER. 2018Buy$15K – $50KSep 8
    • BSXBoston Scientific Corporation Common Stock (BSX)Partial sell$50K – $100KSep 4
    • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
    • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
    • BSXBoston Scientific Corporation Common Stock (BSX)Sell$1K – $15KSep 3
    • BSXBoston Scientific Corporation Common Stock (BSX)Sell$50K – $100KSep 9
    + 42 more trades in this filing
    Made public 29 days after the earliest trade

    Hern's 99-trade filing is a near-wholesale exit from energy and industrials, with Devon Energy sold down in three separate blocks of $100,001 to $250,000 and a same-size Exxon trim, while the only buys are Oklahoma municipal bonds and defensive names like Coca-Cola and Chubb. A House Republican rotating out of oil into tax-free paper is worth noting as his own party campaigns on a trading ban.

    Read more

    BSX Coverage

    Load More

    Frequently Asked Questions

    What does Boston Scientific do?

    Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets a broad range of interventional and implantable medical devices. The company operates through two reportable segments: MedSurg (encompassing Endoscopy, Urology, and Neuromodulation) and Cardiovascular.

    What is the BSX stock price target?

    24/7 Wall St.'s 12-month price target for BSX is $51.66, rated Buy. The Wall Street consensus target is $49.60. BSX price prediction →